Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Enzo Biochem Presents New AmpiProbe™ Nucleic Acid Amplification Platform

Published: Monday, April 02, 2012
Last Updated: Monday, April 02, 2012
Bookmark and Share
Data suggests highly efficient and economic platform could be basis for next-generation molecular diagnostics.

Enzo Biochem Inc. announced that the Company has made its first peer-reviewed presentation of its novel AmpiProbe™ platform, encompassing low cost, and high sensitivity, real time nucleic acid amplification and detection assays, at the annual meeting in London of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

The Company’s presentation, titled “Quantitative Detection of HCV RNA in Human Plasma-Serum using the Enzo AmpiProbe™ HCV RNA Assay,” detailed the specifications and performance characteristics of the first diagnostic product developed utilizing the AmpiProbe™ platform.

“The assay is the first product based on our next-generation molecular diagnostics platform,” said Elazar Rabbani, CEO of Enzo Biochem. “Our plan is to systematically introduce a number of additional products that could deliver a panel of relevant diagnostics that can be performed simultaneously from a single clinical sample, a program now underway. The objective is to develop assays that are expected to provide a cost-effective solution to clinical labs while providing physicians with more comprehensive medical information on a highly economic and time consuming basis.”

Enzo‘s AmpiProbe™ Hepatitis C virus RNA assay was tested over hundreds of clinical samples and found to be reproducible, accurate and precise, the presentation indicated. The assay was found to be highly specific to HCV, showing no cross reactivity to other infectious viruses and no susceptibility to potentially interfering substances associated with clinical samples. In addition, the AmpiProbe™ HCV RNA assay was found, as compared to similar diagnostics products, to achieve a greater enhanced sensitivity that allows for a more convenient and efficient workflow requiring significantly less starting material. The data also suggests that it may facilitate paneling of multiple independent assays from the standard amount of starting material.

The Company recently announced that it had completed a submission to the New York State Department of Health seeking approval to utilize this assay as a laboratory developed test and that it also has commenced the process for obtaining CE-IVD (Conformité Européenne in vitro diagnostic) designation, which would allow it to market its HCV RNA assay as a diagnostic product in the European Union.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Enzo Clinical Lab and DiaSorin Collaborate
The collaboration will enable the DiaSorin to provide physician-clients in metropolitan New York with advanced diagnostic tools.
Friday, October 18, 2013
Enzo and NIH File Patent Application for Autoimmune Diseases
Collaborators filed a patent application for the management of autoimmune diseases that may include age-related macular degeneration (AMD), which is a leading cause of blindness in the United States.
Thursday, May 09, 2013
Enzo Biochem Announces Expanded Distribution Agreement with Japan’s Cosmo Bio
Under the terms of the arrangement, Cosmo Bio will assume a leadership position in Japan in the promotion, sales, and high level technical and customer support for Enzo Life Sciences products.
Wednesday, March 21, 2012
Scientific News
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!